This report provides a detailed description of transplanting murine thymi from different aged donor mice under the kidney capsule of immunodeficient mouse recipients. The goal of this approach is to model T cell development and thymic selection events in vivo.
The mechanisms that regulate the efficacy of thymic selection remain ill-defined. The method presented here allows in vivo analyses of the development and selection of T cells specific for self and foreign antigens. The approach entails implantation of thymic grafts derived from various aged mice into immunodeficient scid recipients. Over a relatively short period of time the recipients are fully reconstituted with T cells derived from the implanted thymus graft. Only thymocytes seeding the thymus at the time of isolation undergo selection and develop into mature T cells. As such, changes in the nature and specificity of the engrafted T cells as a function of age-dependent thymic events can be assessed. Although technical expertise is required for successful thymic transplantation, this method provides a unique strategy to study in vivo a wide range of pathologies that are due to or a result of aberrant thymic function and/or homeostasis.
The thymus is an organ in which critical events in T cell development occur1. Resident thymocytes, upon rearrangement of the T cell receptor (TCR) α and β genes, undergo a series of interactions with lymphostromal and antigen presenting cells (APC) in the cortical and medullary regions of the thymus2. Thymic positive selection is mediated by cortical thymic epithelial cells (TEC) to produce thymocytes that recognize antigenic peptides in the context of host major histocompatibility complex (MHC) class I and II molecules2-3. Subsequent thymic negative selection entails purging of autoreactive thymocytes, driven by an interaction with medullary TEC or dendritic cells (DC) that present peptides derived from self-proteins bound by MHC class I and II molecules3. The end result of these processes is the establishment of a pool of mature CD4+ and CD8+ T cells able to respond to a broad spectrum of foreign antigens while exhibiting minimal reactivity to self-proteins4.
The efficiency of thymic selection events is influenced by a host of factors, including thymic maturation, frequency of medullary and cortical TEC, subset composition of thymic DC, and the source of thymic precursors3. Notably, aberrant thymic selection can result in autoimmune5 or immunodeficient pathologies, which arise from impaired negative or positive selection, respectively. The molecular events regulating thymic selection, however, are poorly understood. In vitro approaches such as reaggregate thymic organ cultures (RTOC)6, have proven to be useful for analyzing basic events associated with thymic selection, but fail to fully recapitulate the dynamics of ongoing in vivo events. As a result, this thymic transplantation-based approach was established to better study thymocyte selection events in vivo7.
This protocol describes transplanting thymi from newborn and adult donor mice into immunodeficient scid recipient mice. This technique permits the study of mechanisms that regulate positive and negative thymic selection, as well as thymic output of various T cell subsets during ontogeny. Most recently, this approach has been used to demonstrate that the efficiency of thymic selection is limited early after birth in mice leading to increased development of autoreactive T cells, and a reduced T cell repertoire specific for foreign antigens7.
The murine studies were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of North Carolina Chapel Hill and all animal care was in accordance with the IACUC guidelines.
1. Preparation of Newborn and Adult Thymi
2. Thymus Implantation Under the Kidney Capsule
The success of this procedure is dependent on minimal surgical trauma as well as the accurate positioning of the graft underneath the kidney capsule. The thymic graft should be cut to ensure appropriately sized thymic sections for subsequent transplantation as shown in Figure 1. Following the schematic in Figure 1, thymi from newborn or adult mice can be used for successful subcapsular transplantation with consistent and reproducible T cell engraftment results. As mentioned, appropriate positioning of the graft under the kidney capsule is important in maintaining long-term survival, function, and vascularization of the graft. As seen in Figure 2, the thymic graft should be placed atop the kidney, closest to the adrenal glands (anterior of kidney), on the opposite end from the capsular incision (posterior of kidney). A successful thymic transplant, when coupled with an appropriate hematopoietic environment, can remain productive in excess of 30 weeks7.
Following transplantation, engraftment is assessed by flow cytometric analyses of T cells obtained from peripheral blood. Figure 3 and Table 2 demonstrate the typical level of T cell engraftment observed in organs and peripheral blood in a transplant recipient 6 weeks post-transplantation. Using this technique, our group has previously shown the kinetics of CD4+ and CD8+ T cell reconstitution in peripheral blood over time in transplant recipients of newborn and adult thymi. Briefly, circulating T cells can be observed in the periphery within one week post-surgery and CD4+ and CD8+ T cell numbers continue to increase until the peripheral T cell compartment is fully reconstituted at 5-6 weeks post transplantation7.
Figure 1: Preparation of thymic lobes and sections from donor newborn and adult mice. Donor thymi are excised from 1 day-old (N.B.) and 4 week-old (Adult). Dashed lines are presented as a guide for preparing the maximum number of sections from one donor organ for subsequent transplantation.
Figure 2: Position of capsular incision and placement of thymic graft. An appropriately sized section prepared from the donor thymus is inserted into the subcapsular space created by a small incision in the renal capsule at the posterior end of the kidney (A). Anterior to the kidney, closest to the adrenal glands (not pictured) and at the opposite end from the capsular incision, is the optimal position for the graft that is inserted underneath the capsule as shown in (B).
Figure 3. Determining successful engraftment via T cell reconstitution in peripheral blood and lymphoid organs. Flow cytometric data are representative of T cell reconstitution observed 6 weeks post-transplantation in a scid recipient of a N.B. thymic graft. Similar levels of T cell engraftment are observed in peripheral blood, spleen, pancreatic lymph node (PLN), and the mesenteric lymph node (MLN) following successful transplantation of a thymic graft.
Fine Dissecting forceps |
Medium Dissecting forceps (2) |
Fine dissecting forceps (curved tip) |
Betadine Solution |
70% Ethanol |
18 gauge needle |
Dissecting microscope w/light source |
Disposable transfer pipettes (2) |
Drugs for pain management: Acetaminophen |
Sterile wipes |
Heat lamp |
Electric razor |
Isoflurane and isoflurane vaporizer |
Sutures (fast absorbing, plain gut) |
Dissecting Scissors |
9 mm Stainless Steel Wound clips |
Wound clip removal tool |
Sterile 1x PBS |
60 mm Dish |
Table 1: Materials needed during surgical thymic transplantation. List of necessary materials used to implant the thymus underneath the kidney capsule of the recipient mouse. The quantity of specified materials is listed in parenthesis.
Total Number of CD4 T cells | Total Number of CD8 T cells | |
Blood | 1,652 cells/υl | 351 cells/υl |
Spleen | 11,546,617 | 4,203,299 |
PLN | 1,241,789 | 364,918 |
MLN | 2,182,266 | 532,059 |
Table 2. Total number of T cells present in peripheral blood and lymphoid organs of a thymic transplant recipient. Total numbers of CD4+ and CD8+ T cells recovered from the organs as well as peripheral blood of a newborn thymic transplant recipient 6 weeks post-transplantation. These numbers are representative of CD4+ and CD8+ T cell cellularity that is typically observed in successful newborn and adult thymic transplant recipients.
Events regulating thymic selection are poorly understood. Recent studies have demonstrated ontogenic changes in the efficiency of selection. Coupling this approach with different transgenic thymus donor and recipient mice will further facilitate studies to identify the events and parameters that regulate thymic selection. Notably, thymic transplantation is used for the treatment and management of T cell and thymic disorders seen for instance in athymic infants lacking functional T cells and in patients with DiGeorge syndrome, characterized by thymic hypoplasia or thymic aplasia9-10. Thymus transplantation, like most organ transplantation, is not free of complications, which are mostly due to transplant tolerance-related complications12 and development of autoimmune pathologies11. These issues, coupled with the need to better understand and characterize mechanisms involved in thymocyte tolerance induction led to the development of this method. The protocol described herein experimentally models thymic transplantation and demonstrates that efficient T cell reconstitution is obtained in recipients.
There are several key points to note in the protocol. It is necessary to be adept at surgery and aseptic technique prior to performing the transplantation surgery. Adherence to this will help minimize trauma, the time the mouse is anesthetized, and recovery time so that 100% post-surgery survival rate can be readily obtained. When preparing the donor thymus, it is imperative that the organ is kept on wet ice to minimize cell death. In addition the thymic lobes need to be cut to appropriate sized fragments to permit implantation without tearing the kidney capsule. Similarly, care is required to prevent any injury to the kidney upon making the incision of the renal capsule. Placement of the thymic graft underneath the kidney capsule is another important step in the process. Injury to the kidney or tearing of the renal capsule can be avoided with gentle handling, using appropriate fine-tipped surgical tools, and sufficient practice. One possibility to note is that successful T cell engraftment may also be achieved by implanting thymic lobes at sites other than under the kidney capsule, for instance at a subcutaneous site. The kidney however provides an ideal environment to receive thymic grafts due to a high level of vascularization, which promotes both graft survival as well as efficient T cell trafficking following thymic selection.
A distinct advantage of the above thymus transplant protocol is the technical ease in determining T cell engraftment. Using flow cytometry, success of the procedure is qualitatively and quantitatively assessed by measuring the frequency of T cells in peripheral blood. In addition to observing mature T cells in the blood, T cell engraftment is detected in various lymphoid organs. The latter permits further study of the expansion, activation, and differentiation of peripheral T cells in various host genetic environments under physiological conditions. One caveat that investigators may consider when interpreting results is that following thymic engraftment into an immunodeficient recipient, newly selected T cells will undergo lymphopenic expansion in the periphery. Although this rapid expansion will not alter thymic selection events, it may lead to preferential expansion of distinct T cell subsets in peripheral tissues.
This protocol is widely applicable for studying mechanisms regulating T cell development and homeostasis in a variety of pathologies. For example, this approach can be used to study FoxP3 regulatory T cell generation and development7,13-14, as well as T cell renewal and export from the thymus in in vivo models of persistent viral, fungal, or bacterial infection15. In summary, this article describes a method of thymus transplantation that entails minimal manipulation of donor tissue, and a high success rate once the technique has been mastered.
The authors have nothing to disclose.
This work was supported by funding received from the National Institutes of Health (1R01AI083269).
Ethanol | Decon Laboratories | 2705HC | |
PBS | GIBCO | 14190-144 | pH 7.2 |
Betadine Solution | Purdue Products | 67618-150-17 | |
18 gauge needle | BD | 305195 | |
Sutures (1.0 metric) | Ethicon | J493G | 18" (45cm) |
AUTOCLIP Wound Clips (9mm) | Clay Adams® Brand | 427631 | |
Transfer pipette | Fisher Scientific | 13-711-20 | Sterile, disposable |
Mouse anti-CD3 Ab | eBioscience | 11-0031-85 | Clone: 1452C11 |
Mouse anti-CD4 Ab | eBioscience | 48-0042-82 | Clone: RM4-5 |
Mouse anti-CD8 Ab | eBioscience | 25-0081-82 | Clone: 53-6.7 |
Lancet | Medipoint | Goldenrod 4mm | |
Pacific Orange Succinimidyl Ester, Triethylammonium Salt | Invitrogen | P30253 | |
96-well round botton polypropylene plates | Corning | 3365 | |
1.2mL polypropylene cluster tubes | Corning | 4401 | |
5mL polypropylene round-bottom tubes | BD | 352002 | |
40uM Nylon Cell Strainer | Falcon | 352340 | |
16% Paraformaldehyde Solution, EM Grade | Electron Microscopy Services | 15710 | Hazardous |
Puralube Optical Ointment | Fisher Scientific | NC0138063 | |
Lympholyte | Cedarlane | CL5030 | |
60 mm cell culture dish | Corning | 430196 | 60mm x 15mm, Sterile |